Aspire Biopharma Holdings, Inc. ASBP
Set alert
8.11 USD -0.52 -6.03%
At close · Oct 30
8.36 +0.25 +3.08%
After hours · Oct 30, 4:00 PM ET
8.00 Day range 8.46
0.155 52-week range 15.32
- YTD
- +53.60%
- 1 year
- -46.08%
- Open
- 8.46
- Prev close
- 8.63
- Mkt cap
- 11.37M
- Vol
- 20.29K
- Avg vol
- 31.46K
- EPS
- -30.89
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.00
- High
- 8.46
Financial health
Altman Z-Score
-3.46 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 5
Valuation
P/E -9.7×
FY 2021 5y median -9.7× FY 2025
P/S 38181×
FY 2021 5y median 0.0× FY 2025
P/B -37.1×
FY 2021 5y median -37.1× FY 2025
P/FCF -48.1×
FY 2021 5y median -2204× FY 2025
EV/EBITDA -20.9×
FY 2021 5y median -20.9× FY 2025
EV/Sales 38243×
FY 2021 5y median 0.0× FY 2025
FCF Yield -2.1%
FY 2021 5y median -0.0% FY 2025
Profitability
Gross Margin -1.9%
FY 2021 5y median 0.0% FY 2025
Operating Margin -312016.9%
FY 2021 5y median 0.0% FY 2025
Net Margin -394725.1%
FY 2021 5y median 0.0% FY 2025
ROE 383.9%
FY 2021 5y median 85.1% FY 2025
ROIC 395.3%
FY 2021 5y median -4.8% FY 2025
ROA -1865.7%
FY 2021 5y median -8.7% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2021 FY 2025
Operating Income -1498.1%
FY 2021 FY 2025
EPS (diluted) 52.1%
FY 2021 FY 2025
Free Cash Flow -1756.6%
FY 2021 FY 2025
Financial Health
Current Ratio 0.2×
FY 2021 5y median 0.2× FY 2025
Quick Ratio 0.1×
FY 2021 5y median 0.2× FY 2025
Debt / Equity -0.2×
FY 2021 5y median -0.2× FY 2025
Net Debt / EBITDA -0.0×
FY 2021 5y median 0.0× FY 2025
Interest Coverage -2.3×
FY 2021 5y median -2.3× FY 2025
Dividends
Dividend Yield 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31